Back to overview

Team Ventures

ArkeaBio

Year of investment: 2024

Food & Agri

Early stage

Ventures

Active

USA

ArkeaBio develops a livestock vaccine to reduce methane from cattle across different feeding systems without compromising animal welfare.

A partnership built for impact

Our investment supports a scalable, easy-to-use methane-reduction tool that can lower the climate footprint of livestock production.

“Reducing methane from livestock is one of the most urgent opportunities in agricultural climate action. Arkea is developing a solution that fits naturally into existing farming practices and has the potential to scale across production systems. We believe this could become an important tool for farmers, food companies, and the broader dairy and beef value chain.”

— Katrien Swerts, Executive Director at Rabo Investments